Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications

Available treatments for hepatitis B can control the virus but are rarely curative. This led to a global initiative to design new curative therapies for the 257 million patients affected. Discovery and development of these new therapies is contingent upon functional in vitro and in vivo hepatitis B...

Descripción completa

Detalles Bibliográficos
Autores principales: Wettengel, Jochen M., Linden, Bianca, Esser, Knud, Laue, Michael, Burwitz, Benjamin J., Protzer, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402639/
https://www.ncbi.nlm.nih.gov/pubmed/34452368
http://dx.doi.org/10.3390/v13081503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402639/
https://www.ncbi.nlm.nih.gov/pubmed/34452368
http://dx.doi.org/10.3390/v13081503

Ejemplares similares